|
IBRX Immunitybio Inc 1326110 |
| Balance Sheet |
|
Current Assets
|
$452,953,000.00 |
|
Assets
|
$646,637,000.00 |
|
Current Liabilities
|
$67,952,000.00 |
|
Liabilities
|
$1,515,763,000.00 |
|
Equity
|
$-870,006,000.00 |
|
Shares Out
|
1047341146.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-75,359,000.00 |
|
Investing Cash Flow
|
$-31,650,000.00 |
| Market Analysis |
Market Cap
|
$7,802,691,537.70 |
|
Price
|
$7.23 |
|
PB
|
594.00 |
|
EPS
|
-0.62 |
|
PS
|
55.91 |
|
FCF
|
$-77,135,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:17 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:11 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.06 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.62 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.10 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.07 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IBRX documents filed with the SEC.
IBRX Filings
Clear
